ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 709588 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 709588; 2) Community: the network communities that were significantly associated with the response to NSC 709588; 3) Molecule: the relationships between components within communities and NSC 709588; 4) MDR: the compounds that were significantly associated with the NSC 709588.

NSC Compound Enrichment Correlation
NSC 139105 Soluble Baker's Antifol 0.00628187335688596 -0.23620167
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 0.00628187335688596 -0.16274357
NSC 653147 Null 0.00628187335688596 -0.41148354
NSC 665925 Null 0.00628187335688596 -0.30563833
NSC 684481 7H-Pyrido[3,2-d][1]benzazepine-6-thione, 2-(3-chloro- phenyl)-5,6-dihydro-4-phenyl- 0.00628187335688596 0.49658287
NSC 292206 RUSTAIYAN A 0.00628187335688605 -0.3148859
NSC 721049 7Z-Plakortide H 0.00628187335688605 0.020145946
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.00628187335688605 -0.19292586
NSC 736041 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne 0.00628187335688605 -0.35362282
NSC 740 Methotrexate 0.00628187335688605 -0.10947182
Total:56  Current:8    [First] [Prev] [Next] [Last]